Literature DB >> 23486563

LPA Stimulates the Phosphorylation of p130Cas via Gαi2 in Ovarian Cancer Cells.

Jeremy D Ward1, Danny N Dhanasekaran.   

Abstract

Ovarian cancer is the most deadly gynecological cancer, with previous studies implicating lysophosphatidic acid (LPA) in the progression of approximately 90% of all ovarian cancers. LPA potently stimulates the tyrosine phosphorylation of p130Cas, a scaffolding protein, which, upon phosphorylation, recruits an array of signaling molecules to promote tumor cell migration. Our work presented here identifies Gαi2 as the major G protein involved in tyrosine phosphorylation of p130Cas in a panel of ovarian cancer cells consisting of HeyA8, SKOV3, and OVCA429. Our results also indicate that the G12 family of G proteins that are also involved in LPA-mediated migration inhibits tyrosine phosphorylation of p130Cas. Using p130Cas siRNA, we demonstrate that p130Cas is a necessary downstream component of LPA Gαi2-induced migration and collagen-1 invasion of ovarian cancer cells. Considering the fact that LPA stimulates invasive migration through the coordination of multiple downstream signaling pathways, our current study identifies a separate unique signaling node involving p130Cas and Gαi2 in mediating LPA-mediated invasive migration of ovarian cancer cells.

Entities:  

Keywords:  G protein; Gαi2; LPA; migration; ovarian cancer; p130Cas

Year:  2012        PMID: 23486563      PMCID: PMC3591094          DOI: 10.1177/1947601913475360

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  51 in total

1.  Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist.

Authors:  Brian H Heasley; Renata Jarosz; Kevin R Lynch; Timothy L Macdonald
Journal:  Bioorg Med Chem Lett       Date:  2004-06-07       Impact factor: 2.823

2.  Differential translocation of rho family GTPases by lysophosphatidic acid, endothelin-1, and platelet-derived growth factor.

Authors:  I N Fleming; C M Elliott; J H Exton
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

3.  Subsets of the major tyrosine phosphorylation sites in Crk-associated substrate (CAS) are sufficient to promote cell migration.

Authors:  Nah-Young Shin; Rebecca S Dise; Jens Schneider-Mergener; Marylyn D Ritchie; Dawn M Kilkenny; Steven K Hanks
Journal:  J Biol Chem       Date:  2004-07-06       Impact factor: 5.157

Review 4.  The ins and outs of lysophosphatidic acid signaling.

Authors:  Wouter H Moolenaar; Laurens A van Meeteren; Ben N G Giepmans
Journal:  Bioessays       Date:  2004-08       Impact factor: 4.345

5.  Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway.

Authors:  Dafang Bian; Shibing Su; Chitladda Mahanivong; Robert K Cheng; Qiwei Han; Zhixing K Pan; Peiqing Sun; Shuang Huang
Journal:  Cancer Res       Date:  2004-06-15       Impact factor: 12.701

6.  Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas.

Authors:  H Honda; H Oda; T Nakamoto; Z Honda; R Sakai; T Suzuki; T Saito; K Nakamura; K Nakao; T Ishikawa; M Katsuki; Y Yazaki; H Hirai
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

7.  A novel series of 2-pyridyl-containing compounds as lysophosphatidic acid receptor antagonists: development of a nonhydrolyzable LPA3 receptor-selective antagonist.

Authors:  Brian H Heasley; Renata Jarosz; Karen M Carter; S Jenny Van; Kevin R Lynch; Timothy L Macdonald
Journal:  Bioorg Med Chem Lett       Date:  2004-08-02       Impact factor: 2.823

8.  A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action.

Authors:  G B Mills; C May; M McGill; C M Roifman; A Mellors
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

9.  Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells.

Authors:  A Frankel; G B Mills
Journal:  Clin Cancer Res       Date:  1996-08       Impact factor: 12.531

10.  Lysophospholipids activate ovarian and breast cancer cells.

Authors:  Y Xu; X J Fang; G Casey; G B Mills
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

View more
  16 in total

1.  Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.

Authors:  Ji Hee Ha; Jeremy D Ward; Rangasudhagar Radhakrishnan; Muralidharan Jayaraman; Yong Sang Song; Danny N Dhanasekaran
Journal:  Oncotarget       Date:  2016-06-21

2.  LPA-mediated migration of ovarian cancer cells involves translocalization of Gαi2 to invadopodia and association with Src and β-pix.

Authors:  Jeremy D Ward; Ji Hee Ha; Muralidharan Jayaraman; Danny N Dhanasekaran
Journal:  Cancer Lett       Date:  2014-10-13       Impact factor: 8.679

3.  The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.

Authors:  Ji Hee Ha; Jeremy D Ward; Lakshmi Varadarajalu; Sang Geon Kim; Danny N Dhanasekaran
Journal:  Cell Signal       Date:  2013-09-19       Impact factor: 4.315

4.  Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma.

Authors:  Hadil Onallah; Liora Jacobs Catane; Claes G Tropé; Thea E Hetland Falkenthal; Reuven Reich; Ben Davidson
Journal:  Virchows Arch       Date:  2018-07-21       Impact factor: 4.064

5.  Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells.

Authors:  Silvia Caggia; HimaBindu Chunduri; Ana C Millena; Jonathan N Perkins; Smrruthi V Venugopal; BaoHan T Vo; Chunliang Li; Yaping Tu; Shafiq A Khan
Journal:  J Cell Physiol       Date:  2018-08-04       Impact factor: 6.384

6.  Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.

Authors:  Yan Liao; Ganggang Mu; Lingli Zhang; Wei Zhou; Jun Zhang; Honggang Yu
Journal:  Dig Dis Sci       Date:  2013-09-24       Impact factor: 3.199

Review 7.  The LPA3 Receptor: Regulation and Activation of Signaling Pathways.

Authors:  Karina Helivier Solís; M Teresa Romero-Ávila; Alejandro Guzmán-Silva; J Adolfo García-Sáinz
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

8.  Determinant role for the gep oncogenes, Gα12/13, in ovarian cancer cell proliferation and xenograft tumor growth.

Authors:  Ji Hee Ha; Rohini Gomathinayagam; Mingda Yan; Muralidharan Jayaraman; Rajagopal Ramesh; Danny N Dhanasekaran
Journal:  Genes Cancer       Date:  2015-07

9.  Suppression of GNAI2 message in ovarian cancer.

Authors:  John R Raymond; Kathryn M Appleton; Jennifer Y Pierce; Yuri K Peterson
Journal:  J Ovarian Res       Date:  2014-01-14       Impact factor: 4.234

10.  Hax-1 is required for Rac1-Cortactin interaction and ovarian carcinoma cell migration.

Authors:  Rohini Gomathinayagam; Jayaraman Muralidharan; Ji Hee Ha; Lakshmi Varadarajalu; Danny N Dhanasekaran
Journal:  Genes Cancer       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.